{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:13:10Z","timestamp":1762431190141,"version":"3.40.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neuint.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T18:55:14Z","timestamp":1473706514000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Clinical trial design for stem cell therapies in stroke: What have we learned?"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-022X","authenticated-orcid":false,"given":"Keith W.","family":"Muir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neuint.2016.09.011_bib1","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.5966\/sctm.2013-0178","article-title":"Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke","volume":"3","author":"Banerjee","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"6","key":"10.1016\/j.neuint.2016.09.011_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2009.10.010","article-title":"Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection","volume":"221","author":"Barbosa da Fonseca","year":"2010","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/rme.10.97","article-title":"Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke","volume":"6","author":"Battistella","year":"2011","journal-title":"Regen. Med."},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000333381","article-title":"Autologous mesenchymal stem cells in chronic stroke","volume":"1","author":"Bhasin","year":"2011","journal-title":"Cerebrovasc. Dis. Extra"},{"issue":"6 Suppl.\u00a03","key":"10.1016\/j.neuint.2016.09.011_bib6","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1161\/CIRCOUTCOMES.115.002098","article-title":"Chronic stroke outcome measures for motor function intervention trials: expert panel recommendations","volume":"8","author":"Bushnell","year":"2015","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"issue":"6","key":"10.1016\/j.neuint.2016.09.011_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.24653","article-title":"Emergent properties of neural repair: elemental biology to therapeutic concepts","volume":"79","author":"Carmichael","year":"2016","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.expneurol.2005.01.004","article-title":"Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex","volume":"193","author":"Carmichael","year":"2005","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.neuint.2016.09.011_bib9","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3727\/096368909X474230","article-title":"Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in\u00a0vivo imaging and biodistribution","volume":"18","author":"Detante","year":"2009","journal-title":"Cell Transpl."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuint.2016.09.011_bib10","first-page":"852","article-title":"Intravenous injection of autologous mesenchymal stem cells after ischemic stroke (ISIS\/HERMES): protocol and progress","volume":"35","author":"Detante","year":"2013","journal-title":"Cerebrovasc. Dis."},{"issue":"9958","key":"10.1016\/j.neuint.2016.09.011_bib11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/01.STR.0000155197.88944.ac","article-title":"Correlation of systemic inflammatory response with infarct volume in acute ischemic stroke patients","volume":"36","author":"Emsley","year":"2005","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.neuint.2016.09.011_bib13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nn.2377","article-title":"Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation","volume":"12","author":"Garcia-Alias","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1308\/rcsbull.2016.75","article-title":"When should placebo surgery as a control in clinical trials be carried out?","volume":"98","author":"George","year":"2016","journal-title":"Bull. R. Coll. Surg. Engl."},{"issue":"4","key":"10.1016\/j.neuint.2016.09.011_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12975-012-0208-3","article-title":"Human umbilical cord blood cells alter blood and spleen cell populations after stroke","volume":"3","author":"Golden","year":"2012","journal-title":"Transl. Stroke Res."},{"issue":"10029","key":"10.1016\/j.neuint.2016.09.011_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.expneurol.2011.02.021","article-title":"Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis","volume":"230","author":"Grigoriadis","year":"2011","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neuint.2016.09.011_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ijs.12065","article-title":"A\u00a0double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke","volume":"9","author":"Hess","year":"2014","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.neuint.2016.09.011_bib19","article-title":"Results of the double-blind, randomized, placebo controlled, phase 2 safety and efficacy trial of MULTISTEM (R) in adults with ischemic stroke","volume":"10","author":"Hess","year":"2015","journal-title":"Int. J. Stroke"},{"issue":"Pt 6","key":"10.1016\/j.neuint.2016.09.011_bib20","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neuint.2016.09.011_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuint.2011.03.016","article-title":"Stem cell therapy in stroke: designing clinical trials","volume":"59","author":"Kalladka","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2016.09.011_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Pilot investigation of human neural stem cells in chronic ischaemic stroke patients (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1474-4422(13)70305-3","article-title":"Three-dimensional, task-specific robot therapy of the arm after stroke: a multicentre, parallel-group randomised trial","volume":"13","author":"Klamroth-Marganska","year":"2014","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.neuint.2016.09.011_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(09)70202-9","article-title":"Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling","volume":"8","author":"Koch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2016.09.011_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"J.\u00a0Neurosurg."},{"issue":"11","key":"10.1016\/j.neuint.2016.09.011_bib27","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.STR.0000092527.33910.89","article-title":"Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke","volume":"34","author":"Krams","year":"2003","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neuint.2016.09.011_bib28","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","article-title":"Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010","volume":"1","author":"Krishnamurthi","year":"2013","journal-title":"Lancet Glob. Health"},{"issue":"44","key":"10.1016\/j.neuint.2016.09.011_bib29","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1002\/adfm.201401483","article-title":"Delivery of iPS-NPCs to the stroke cavity within a hyaluronic acid matrix promotes the differentiation of transplanted cells","volume":"24","author":"Lam","year":"2014","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.neuint.2016.09.011_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A\u00a0long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.neuint.2016.09.011_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1747-4949.2012.00797.x","article-title":"Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis","volume":"7","author":"Lees","year":"2012","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"issue":"3","key":"10.1016\/j.neuint.2016.09.011_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/jcbfm.2009.238","article-title":"Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study","volume":"30","author":"Li","year":"2010","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"issue":"7097","key":"10.1016\/j.neuint.2016.09.011_bib34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nature04960","article-title":"Stem cells for the treatment of neurological disorders","volume":"441","author":"Lindvall","year":"2006","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.neuint.2016.09.011_bib35","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa0911341","article-title":"Robot-assisted therapy for long-term upper-limb impairment after stroke","volume":"362","author":"Lo","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"8","key":"10.1016\/j.neuint.2016.09.011_bib36","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.09.011_bib37","doi-asserted-by":"crossref","first-page":"g4757","DOI":"10.1136\/bmj.g4757","article-title":"Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis","volume":"349","author":"Morris","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.neuint.2016.09.011_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/WCO.0b013e32813ba151","article-title":"Inflammation and ischaemic stroke","volume":"20","author":"Muir","year":"2007","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.neuint.2016.09.011_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12975-011-0095-z","article-title":"Intracranial delivery of stem cells","volume":"2","author":"Muir","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.09.011_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.copbio.2016.04.021","article-title":"Hydrogels for brain repair after stroke: an emerging treatment option","volume":"40","author":"Nih","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"issue":"9","key":"10.1016\/j.neuint.2016.09.011_bib41","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STROKEAHA.109.575993","article-title":"Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia","volume":"41","author":"Pendharkar","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib42","first-page":"221","article-title":"Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study","volume":"136","author":"Prasad","year":"2012","journal-title":"Indian J. Med. Res."},{"issue":"12","key":"10.1016\/j.neuint.2016.09.011_bib43","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/rme.13.2","article-title":"Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients","volume":"8","author":"Rosado-de-Castro","year":"2013","journal-title":"Regen. Med."},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ijs.12022","article-title":"Changes in spleen size in patients with acute ischemic stroke: a pilot observational study","volume":"8","author":"Sahota","year":"2013","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.STR.0000196957.55928.ab","article-title":"Time is brain\u2013quantified","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neuint.2016.09.011_bib47","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/STROKEAHA.115.007149","article-title":"Developing cellular therapies for stroke","volume":"46","author":"Savitz","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2016.09.011_bib50","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","article-title":"Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials","volume":"45","author":"Savitz","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neuint.2016.09.011_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1747-4949.2012.00840.x","article-title":"Stem cells in stroke treatment: the promise and the challenges","volume":"7","author":"Sinden","year":"2012","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"key":"10.1016\/j.neuint.2016.09.011_bib52","first-page":"119","article-title":"Prospects for stem cell-derived therapy in stroke","author":"Sinden","year":"2012","journal-title":"Funct. Neural Transplant. Iii Prim. Stem Cell Ther. For Brain Repair Pt Ii"},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2011.03.012","article-title":"The risk of putting something where it does not belong: mesenchymal stem cells produce masses in the brain","volume":"230","author":"Snyder","year":"2011","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2016.09.011_bib54","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","volume":"47","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.neuint.2016.09.011_bib55","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1474-4422(10)70247-7","article-title":"Prediction of recovery of motor function after stroke","volume":"9","author":"Stinear","year":"2010","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neuint.2016.09.011_bib56","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.STR.26.11.2135","article-title":"Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats","volume":"26","author":"Stroemer","year":"1995","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.neuint.2016.09.011_bib57","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1545968309335978","article-title":"The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion","volume":"23","author":"Stroemer","year":"2009","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"1","key":"10.1016\/j.neuint.2016.09.011_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/scd.2012.0404","article-title":"Challenges enrolling patients with acute ischemic stroke into cell therapy trials","volume":"22","author":"Vahidy","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"6","key":"10.1016\/j.neuint.2016.09.011_bib59","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/STROKEAHA.116.012701","article-title":"Systematic review and meta-analysis of bone marrow-derived mononuclear cells in animal models of ischemic stroke","volume":"47","author":"Vahidy","year":"2016","journal-title":"Stroke"},{"issue":"14","key":"10.1016\/j.neuint.2016.09.011_bib60","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","article-title":"Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke","volume":"82","author":"Vu","year":"2014","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.neuint.2016.09.011_bib61","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.296.17.2095","article-title":"Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial","volume":"296","author":"Wolf","year":"2006","journal-title":"J.\u00a0Am. Med. Assoc."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616303047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616303047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T10:28:20Z","timestamp":1536402500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018616303047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":61,"alternative-id":["S0197018616303047"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2016.09.011","relation":{},"ISSN":["0197-0186"],"issn-type":[{"type":"print","value":"0197-0186"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical trial design for stem cell therapies in stroke: What have we learned?","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}